CME Group Inc. (NASDAQ:CME) is Capital Counsel LLC NY’s 9th Largest Position

Capital Counsel LLC NY lifted its holdings in CME Group Inc. (NASDAQ:CME) by 0.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 829,324 shares of the financial services provider’s stock after buying an additional 3,986 shares during the period. CME Group makes up 7.9% of Capital Counsel LLC NY’s holdings, making the stock its 9th biggest position. Capital Counsel LLC NY owned 0.23% of CME Group worth $182,990,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. increased its stake in shares of CME Group by 0.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after acquiring an additional 45 shares during the last quarter. CVA Family Office LLC raised its stake in CME Group by 11.8% during the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the period. Lester Murray Antman dba SimplyRich boosted its holdings in CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after purchasing an additional 50 shares during the last quarter. Zions Bancorporation N.A. grew its stake in shares of CME Group by 3.7% in the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after buying an additional 54 shares during the period. Finally, Quent Capital LLC increased its holdings in shares of CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after buying an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Performance

Shares of CME stock opened at $234.39 on Wednesday. The firm has a 50 day moving average of $224.18 and a two-hundred day moving average of $211.37. The stock has a market capitalization of $84.46 billion, a PE ratio of 24.65, a P/E/G ratio of 5.29 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $235.18.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the business posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. On average, research analysts predict that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 1.96%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is presently 48.37%.

Analysts Set New Price Targets

A number of research analysts recently commented on CME shares. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a report on Thursday, October 24th. Morgan Stanley increased their price target on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a report on Tuesday, October 8th. Piper Sandler increased their target price on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Finally, TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $224.47.

Insider Buying and Selling

In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. The trade was a 1.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,621 shares of company stock worth $3,441,063. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.